U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.255G>A (p.Leu85=) AND not provided

Germline classification:
Likely benign (5 submissions)
Last evaluated:
Jul 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000587054.34

Allele description [Variation Report for NM_000535.7(PMS2):c.255G>A (p.Leu85=)]

NM_000535.7(PMS2):c.255G>A (p.Leu85=)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.255G>A (p.Leu85=)
Other names:
p.L85L:CTG>CTA
HGVS:
  • NC_000007.14:g.6003788C>T
  • NG_008466.1:g.10319G>A
  • NM_000535.7:c.255G>AMANE SELECT
  • NM_001322003.2:c.-151G>A
  • NM_001322004.2:c.-151G>A
  • NM_001322005.2:c.-151G>A
  • NM_001322006.2:c.255G>A
  • NM_001322007.2:c.35+184G>A
  • NM_001322008.2:c.35+184G>A
  • NM_001322009.2:c.-151G>A
  • NM_001322010.2:c.-151G>A
  • NM_001322011.2:c.-630G>A
  • NM_001322012.2:c.-630G>A
  • NM_001322013.2:c.-151G>A
  • NM_001322014.2:c.255G>A
  • NM_001322015.2:c.-230G>A
  • NP_000526.2:p.Leu85=
  • NP_001308935.1:p.Leu85=
  • NP_001308943.1:p.Leu85=
  • LRG_161t1:c.255G>A
  • LRG_161:g.10319G>A
  • NC_000007.13:g.6043419C>T
  • NM_000535.5:c.255G>A
  • NM_000535.6:c.255G>A
  • NM_000535.7:c.255G>A
  • NR_136154.1:n.342G>A
  • p.L85L
Links:
dbSNP: rs200491279
NCBI 1000 Genomes Browser:
rs200491279
Molecular consequence:
  • NM_001322003.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322004.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322005.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322009.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322010.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322011.2:c.-630G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-630G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322013.2:c.-151G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322015.2:c.-230G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322007.2:c.35+184G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.35+184G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NR_136154.1:n.342G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000535.7:c.255G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001322006.2:c.255G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001322014.2:c.255G>A - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
3

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000806211PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Apr 3, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001155037CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely benign
(Jul 1, 2024)
germlineclinical testing

Citation Link,

SCV001470057Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Likely benign
(Sep 15, 2023)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001929597Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

SCV001957120Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes3not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.

Caminsky NG, Mucaki EJ, Perri AM, Lu R, Knoll JH, Rogan PK.

Hum Mutat. 2016 Jul;37(7):640-52. doi: 10.1002/humu.22972. Epub 2016 Mar 18.

PubMed [citation]
PMID:
26898890
See all PubMed Citations (3)

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV000806211.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001155037.25

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testingnot provided

Description

PMS2: BP4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided3not providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001470057.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus, SCV001929597.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus, SCV001957120.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 11, 2024